Search Results - "Burguin, Anna"
-
1
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines
Published in PloS one (25-06-2020)“…The breast cancer (BC) biomarker HER2 (Human Epidermal Receptor 2) is overexpressed in 25% of BC. Only patients with HER2-positive tumors receive…”
Get full text
Journal Article -
2
Breast Cancer Treatments: Updates and New Challenges
Published in Journal of personalized medicine (19-08-2021)“…Breast cancer (BC) is the most frequent cancer diagnosed in women worldwide. This heterogeneous disease can be classified into four molecular subtypes (luminal…”
Get full text
Journal Article -
3
Secreted Frizzled-Related Protein 1 as a Biomarker against Incomplete Age-Related Lobular Involution and Microcalcifications’ Development
Published in Cancers (21-09-2020)“…As a downregulator of the Wnt signaling pathway, SFRP1 is involved in several components of the age-related lobular involution process such as inflammation,…”
Get full text
Journal Article -
4
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments
Published in Journal of clinical medicine (24-06-2023)“…Breast cancer (BC) is a heterogenous disease classified into four molecular subtypes (Luminal A, Luminal B, HER2 and triple-negative (TNBC)) depending on the…”
Get full text
Journal Article -
5
Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients
Published in Journal of personalized medicine (28-08-2021)“…Cannabinoid receptors (CBR) are potential therapeutic targets for breast cancer. However, the role of CBR in breast cancer survival remains poorly understood…”
Get full text
Journal Article